402 related articles for article (PubMed ID: 37447164)
1. Exploring the Impact of Nutrition on Non-Alcoholic Fatty Liver Disease Management: Unveiling the Roles of Various Foods, Food Components, and Compounds.
Kosmalski M; Frankowski R; Deska K; Różycka-Kosmalska M; Pietras T
Nutrients; 2023 Jun; 15(13):. PubMed ID: 37447164
[TBL] [Abstract][Full Text] [Related]
2. Lean non-alcoholic fatty liver disease patients had comparable total caloric, carbohydrate, protein, fat, iron, sleep duration and overtime work as obese non-alcoholic fatty liver disease patients.
Li C; Guo P; Okekunle AP; Ji X; Huang M; Qi J; Jiang Y; Feng R; Li R
J Gastroenterol Hepatol; 2019 Jan; 34(1):256-262. PubMed ID: 29949199
[TBL] [Abstract][Full Text] [Related]
3. From sugar to liver fat and public health: systems biology driven studies in understanding non-alcoholic fatty liver disease pathogenesis.
Moore JB
Proc Nutr Soc; 2019 Aug; 78(3):290-304. PubMed ID: 30924429
[TBL] [Abstract][Full Text] [Related]
4. What's New in the Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD).
Kosmalski M; Frankowski R; Ziółkowska S; Różycka-Kosmalska M; Pietras T
J Clin Med; 2023 Feb; 12(5):. PubMed ID: 36902639
[TBL] [Abstract][Full Text] [Related]
5. The role of nutrition in non-alcoholic fatty liver disease: Pathophysiology and management.
Berná G; Romero-Gomez M
Liver Int; 2020 Feb; 40 Suppl 1():102-108. PubMed ID: 32077594
[TBL] [Abstract][Full Text] [Related]
6. Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease.
Di Minno MN; Russolillo A; Lupoli R; Ambrosino P; Di Minno A; Tarantino G
World J Gastroenterol; 2012 Nov; 18(41):5839-47. PubMed ID: 23139599
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of the Omega-3 Index in predicting non-alcoholic fatty liver disease in overweight and obese adults: a pilot study.
Parker HM; O'Connor HT; Keating SE; Cohn JS; Garg ML; Caterson ID; George J; Johnson NA
Br J Nutr; 2015 Sep; 114(5):780-7. PubMed ID: 26202539
[TBL] [Abstract][Full Text] [Related]
8. Omega-3 Fatty Acids and Fatty Liver Disease in Children.
Corte CD; Iasevoli S; Strologo AD; Sanseviero M; Nobili V
Adv Food Nutr Res; 2018; 85():59-77. PubMed ID: 29860977
[TBL] [Abstract][Full Text] [Related]
9. Nutritional Status and Nutrition Quality in Patients with Non-Alcoholic Fatty Liver Disease.
Vranešić Bender D; Nutrizio M; Jošić M; Ljubas Kelečić D; Karas I; Premužić M; Domislović V; Rotim C; Krznarić Ž
Acta Clin Croat; 2017 Dec; 56(4):625-634. PubMed ID: 29590715
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.
Golabi P; Locklear CT; Austin P; Afdhal S; Byrns M; Gerber L; Younossi ZM
World J Gastroenterol; 2016 Jul; 22(27):6318-27. PubMed ID: 27468220
[TBL] [Abstract][Full Text] [Related]
11. Omega-3 fatty acids and non-alcoholic fatty liver disease: Evidence of efficacy and mechanism of action.
Scorletti E; Byrne CD
Mol Aspects Med; 2018 Dec; 64():135-146. PubMed ID: 29544992
[TBL] [Abstract][Full Text] [Related]
12. Beyond Body Weight-Loss: Dietary Strategies Targeting Intrahepatic Fat in NAFLD.
Worm N
Nutrients; 2020 May; 12(5):. PubMed ID: 32384593
[TBL] [Abstract][Full Text] [Related]
13. [Non-alcoholic fatty liver disease (NAFLD) /non-alcoholic steatohepatitis (NASH) and nutrition].
Ishii KA; Takamura T
Clin Calcium; 2016 Mar; 26(3):363-7. PubMed ID: 26923972
[TBL] [Abstract][Full Text] [Related]
14. Non-alcoholic fatty liver disease and obesity: biochemical, metabolic and clinical presentations.
Milić S; Lulić D; Štimac D
World J Gastroenterol; 2014 Jul; 20(28):9330-7. PubMed ID: 25071327
[TBL] [Abstract][Full Text] [Related]
15. [Lipid metabolism in non-alcoholic fatty liver disease in patients with different body weights in mid-mountain conditions].
Toktogulova NA; Sultanalieva RB; Tuhvatshin RR; Kaliev TK
Ter Arkh; 2023 Jan; 94(12):1361-1366. PubMed ID: 37167179
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease in obese children and adolescents: a role for nutrition?
Bonsembiante L; Targher G; Maffeis C
Eur J Clin Nutr; 2022 Jan; 76(1):28-39. PubMed ID: 34006994
[TBL] [Abstract][Full Text] [Related]
17. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) Study.
Perez-Diaz-Del-Campo N; Marin-Alejandre BA; Cantero I; Monreal JI; Elorz M; Herrero JI; Benito-Boillos A; Riezu-Boj JI; Milagro FI; Tur JA; Martinez JA; Abete I; Zulet MA
Eur J Nutr; 2021 Sep; 60(6):3043-3057. PubMed ID: 33474638
[TBL] [Abstract][Full Text] [Related]
18. Omega-3 fatty acids: Mechanisms of benefit and therapeutic effects in pediatric and adult NAFLD.
Nobili V; Alisi A; Musso G; Scorletti E; Calder PC; Byrne CD
Crit Rev Clin Lab Sci; 2016; 53(2):106-20. PubMed ID: 26463349
[TBL] [Abstract][Full Text] [Related]
19. Fructose as a key player in the development of fatty liver disease.
Basaranoglu M; Basaranoglu G; Sabuncu T; Sentürk H
World J Gastroenterol; 2013 Feb; 19(8):1166-72. PubMed ID: 23482247
[TBL] [Abstract][Full Text] [Related]
20. Effects of a carbohydrate-restricted diet on hepatic lipid content in adolescents with non-alcoholic fatty liver disease: A pilot, randomized trial.
Goss AM; Dowla S; Pendergrass M; Ashraf A; Bolding M; Morrison S; Amerson A; Soleymani T; Gower B
Pediatr Obes; 2020 Jul; 15(7):e12630. PubMed ID: 32128995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
